1. Home
  2. SSBI vs GANX Comparison

SSBI vs GANX Comparison

Compare SSBI & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSBI
  • GANX
  • Stock Information
  • Founded
  • SSBI 1982
  • GANX 2017
  • Country
  • SSBI United States
  • GANX United States
  • Employees
  • SSBI N/A
  • GANX N/A
  • Industry
  • SSBI Major Banks
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSBI Finance
  • GANX Health Care
  • Exchange
  • SSBI Nasdaq
  • GANX Nasdaq
  • Market Cap
  • SSBI 49.9M
  • GANX 41.9M
  • IPO Year
  • SSBI 2006
  • GANX 2021
  • Fundamental
  • Price
  • SSBI $7.69
  • GANX $2.43
  • Analyst Decision
  • SSBI
  • GANX Strong Buy
  • Analyst Count
  • SSBI 0
  • GANX 5
  • Target Price
  • SSBI N/A
  • GANX $7.60
  • AVG Volume (30 Days)
  • SSBI 27.8K
  • GANX 253.7K
  • Earning Date
  • SSBI 01-28-2025
  • GANX 11-14-2024
  • Dividend Yield
  • SSBI 3.64%
  • GANX N/A
  • EPS Growth
  • SSBI N/A
  • GANX N/A
  • EPS
  • SSBI 0.72
  • GANX N/A
  • Revenue
  • SSBI $31,552,000.00
  • GANX N/A
  • Revenue This Year
  • SSBI N/A
  • GANX N/A
  • Revenue Next Year
  • SSBI N/A
  • GANX N/A
  • P/E Ratio
  • SSBI $10.64
  • GANX N/A
  • Revenue Growth
  • SSBI N/A
  • GANX N/A
  • 52 Week Low
  • SSBI $5.68
  • GANX $0.89
  • 52 Week High
  • SSBI $12.35
  • GANX $5.33
  • Technical
  • Relative Strength Index (RSI)
  • SSBI 55.95
  • GANX 71.46
  • Support Level
  • SSBI $6.85
  • GANX $1.55
  • Resistance Level
  • SSBI $7.84
  • GANX $2.65
  • Average True Range (ATR)
  • SSBI 0.34
  • GANX 0.21
  • MACD
  • SSBI 0.01
  • GANX 0.10
  • Stochastic Oscillator
  • SSBI 84.85
  • GANX 80.87

About SSBI Summit State Bank

Summit State Bank provides various banking products and services to individuals and businesses primarily in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.

Share on Social Networks: